www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as

Page 1 of 2 AC6305/006 May 14, 2020 Subject Clarification of the operating results for the quarter 1/2020 ended March 31, 2020 To Director/ Managing Director The Stock Exchange of Thailand According

No. ACC6311/010 12 November, 2020 Subject Clarify the Operating results for quarter 3/2020 ended 30 September, 2020 Attention Director and Manager The Stock Exchange of Thailand According to Advanced

Ref: ACC6401 / 001 March 01, 2021 Subject Clarification of Operating results for the year 2020, Ending December 31, 2020 Attention: Director and Manager The Stock Exchange of Thailand As Advanced

Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to

application. b. Please mark an X in the appropriate box corresponding to your answer c. Send completed and signed forms to - Accounting Supervision Department The Securities and Exchange Commission, Thailand

หน้า 1 ของ 3 (Translation) No. ACC6702/001 February 28, 2024 Subject: Clarification of operating results for the Annual Year 2023 (Revised) To: The President, The Stock Exchange of Thailand Advanced

strengthened on par with securities businesses in general. In addition, more emphasis will be given to the roles of executives responsible for finance and accounting. Information disclosure format will be

assistance To: The President The Stock Exchange of Thailand GFPT Public Company Limited ( “ The Company” or “ GFPT” ) , held the Board of Directors’ meeting no. 8/ 2561 on September 27th, 2018, approved the